Skip to main content

Table 8 Outcomes predicted by models for one birth cohort in Sear-region

From: Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world

  POLYMODa Roxanne CoRoVa
Undiscounted cases    
   Mild 216,205 276,861 299,907
   Moderate 114,255 159,129 127,020
   Severe 11,887 22,086 12,325
   Nosocomial 3,923 4,748 6,309
   Deaths 1,486 2,752 2,366
   Outpatient 126,142 159,129 127,020
   Inpatient (comm. acq.) 11,887 22,086 12,325
Discounted savings    
   Outpatient $1,135,274 $1,391,130 $1,852,744
   Inpatient $2,208,959 $2,975,397 $1,712,409
   Indirect $1,267,227 $1,213,598 $948,564
Discounted net costsb (*1000) $15,424 $ 19,969-39,083 $ 20,545-39,423
Discounted QALYs    
   Mortality 41,822 75,969 65,244
   Morbidity 1,261 1,731 1,462
  1. a. Approximations for one cohort from the multi-cohort results; b. Health-care perspective and range given for previous upper and lower vaccine prices if appropriate.